Literature DB >> 3088647

Antagonism of apomorphine-induced yawning by SCH 23390: evidence against the autoreceptor hypothesis.

M Morelli, R Longoni, L Spina, G Di Chiara.   

Abstract

The ability of apomorphine to induce yawning (YWG) in normal and reserpinized rats and its interaction with SCH 23390, a potent and specific D-1 receptor antagonist, was studied. Apomorphine was more potent in inducing YWG in reserpine-pretreated as compared to control rats. SCH 23390, in low doses (0.05 mg/kg SC), was able to significantly reduce the YWG evoked by apomorphine both in control and in reserpine-pretreated rats. The results indicate that D-1 receptors contribute to YWG elicited by apomorphine and contradict the idea that this effect is mediated by DA autoreceptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088647     DOI: 10.1007/bf00310640

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

Review 1.  Pharmacology and neurochemistry of apomorphine.

Authors:  G Di Chiara; G L Gessa
Journal:  Adv Pharmacol Chemother       Date:  1978

2.  SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia.

Authors:  E Carboni; R Longoni; S Deidda; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1986-06-05       Impact factor: 4.432

3.  Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390.

Authors:  G L Gessa; M L Porceddu; M Collu; G Mereu; M Serra; E Ongini; G Biggio
Journal:  Eur J Pharmacol       Date:  1985-02-26       Impact factor: 4.432

4.  SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.

Authors:  G R Breese; R A Mueller
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

5.  Catalepsy induced by SCH 23390 in rats.

Authors:  M Morelli; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1985-11-05       Impact factor: 4.432

6.  Assessment of dopamine autoreceptor agonist properties of apomorphine, (+)-3-PPP and (-)-3-PPP by recording of yawning behaviour in rats.

Authors:  L Ståhle; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1984-02-17       Impact factor: 4.432

7.  Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.

Authors:  J Arnt
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

8.  Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390.

Authors:  J Hyttel
Journal:  Neuropharmacology       Date:  1984-12       Impact factor: 5.250

9.  The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity.

Authors:  A J Gower; H G Berendsen; M M Princen; C L Broekkamp
Journal:  Eur J Pharmacol       Date:  1984-08-03       Impact factor: 4.432

  9 in total
  13 in total

1.  SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.

Authors:  L Spina; R Longoni; A Mulas; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.

Authors:  A M Zarkovsky; K S Cereska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

3.  Discrepancy in the time course of EMD 23448 induced yawning and reduction of extracellular dopamine.

Authors:  L Ståhle; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Proceedings of the British Pharmacological Society. Ireland, 6th-8th July, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

6.  The reduction of water intake in rats caused by a low dose of apomorphine is unaltered by alpha-methyl-p-tyrosine: are autoreceptors not involved?

Authors:  T Ljungberg; L Ståhle
Journal:  J Neural Transm Gen Sect       Date:  1989

7.  Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.

Authors:  M R Zarrindast; M Poursoltan
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

8.  Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.

Authors:  M R Zarrindast; A Jamshidzadeh
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

9.  The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.

Authors:  I Ushijima; Y Mizuki; M Yamada
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Effects of single and repeated treatment with antidepressants on apomorphine-induced yawning in the rat: the implication of alpha-1 adrenergic mechanisms in the D-2 receptor function.

Authors:  A Delini-Stula; C Hunn
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.